Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)

Linda A. Cernichiaro-Espinosa; Nimesh A. Patel; Mislen S. Bauer; Catherin I. Negron; Brenda Fallas; Alexander Pogrebniak; Audina Berrocal

doi:10.3928/23258160-20190129-16

Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)

Linda A. Cernichiaro-Espinosa, Nimesh A. Patel, Mislen S. Bauer, Catherin I. Negron, Brenda Fallas, Alexander Pogrebniak, Audina Berrocal

Ophthalmology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

No consensus exists for the treatment of retinopathy in incontinentia pigmenti (IP). Vascular ischemia leads to tractional retinal detachments if untreated. Ultra-widefield fluorescein angiography (FA) is used to follow the vascular status of the retina. A 13-week-old female with IP presented with bilateral retinal vascular occlusions in both eyes. Ultra-widefield FA showed reperfusion after treatment with intravitreal bevacizumab (IVB) and angiography-guided laser to the avascular retina. Anti-vascular endothelial growth factor treatment reduces neovascularization and allows for growth of retinal vessels. IVB and FA-guided laser to the avascular retina is an option in IP.

Original language	English (US)
Pages (from-to)	E33-E37
Journal	Ophthalmic Surgery Lasers and Imaging Retina
Volume	50
Issue number	2
DOIs	https://doi.org/10.3928/23258160-20190129-16
State	Published - Feb 1 2019

ASJC Scopus subject areas

Surgery
Ophthalmology

Access to Document

10.3928/23258160-20190129-16

Fingerprint Dive into the research topics of 'Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)'. Together they form a unique fingerprint.

Cite this

Cernichiaro-Espinosa, L. A., Patel, N. A., Bauer, M. S., Negron, C. I., Fallas, B., Pogrebniak, A., & Berrocal, A. (2019). Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmic Surgery Lasers and Imaging Retina, 50(2), E33-E37. https://doi.org/10.3928/23258160-20190129-16

Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome). / Cernichiaro-Espinosa, Linda A.; Patel, Nimesh A.; Bauer, Mislen S.; Negron, Catherin I.; Fallas, Brenda; Pogrebniak, Alexander; Berrocal, Audina.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 50, No. 2, 01.02.2019, p. E33-E37.

Research output: Contribution to journal › Article › peer-review

Cernichiaro-Espinosa, LA, Patel, NA, Bauer, MS, Negron, CI, Fallas, B, Pogrebniak, A & Berrocal, A 2019, 'Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)', Ophthalmic Surgery Lasers and Imaging Retina, vol. 50, no. 2, pp. E33-E37. https://doi.org/10.3928/23258160-20190129-16

Cernichiaro-Espinosa, Linda A. ; Patel, Nimesh A. ; Bauer, Mislen S. ; Negron, Catherin I. ; Fallas, Brenda ; Pogrebniak, Alexander ; Berrocal, Audina. / Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome). In: Ophthalmic Surgery Lasers and Imaging Retina. 2019 ; Vol. 50, No. 2. pp. E33-E37.

@article{702f3ede8eeb453d87e9af4817eeb016,

title = "Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)",

abstract = "No consensus exists for the treatment of retinopathy in incontinentia pigmenti (IP). Vascular ischemia leads to tractional retinal detachments if untreated. Ultra-widefield fluorescein angiography (FA) is used to follow the vascular status of the retina. A 13-week-old female with IP presented with bilateral retinal vascular occlusions in both eyes. Ultra-widefield FA showed reperfusion after treatment with intravitreal bevacizumab (IVB) and angiography-guided laser to the avascular retina. Anti-vascular endothelial growth factor treatment reduces neovascularization and allows for growth of retinal vessels. IVB and FA-guided laser to the avascular retina is an option in IP.",

author = "Cernichiaro-Espinosa, {Linda A.} and Patel, {Nimesh A.} and Bauer, {Mislen S.} and Negron, {Catherin I.} and Brenda Fallas and Alexander Pogrebniak and Audina Berrocal",

year = "2019",

month = feb,

day = "1",

doi = "10.3928/23258160-20190129-16",

language = "English (US)",

volume = "50",

pages = "E33--E37",

journal = "Ophthalmic Surgery Lasers and Imaging Retina",

issn = "2325-8160",

publisher = "Slack Incorporated",

number = "2",

}

TY - JOUR

T1 - Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)

AU - Cernichiaro-Espinosa, Linda A.

AU - Patel, Nimesh A.

AU - Bauer, Mislen S.

AU - Negron, Catherin I.

AU - Fallas, Brenda

AU - Pogrebniak, Alexander

AU - Berrocal, Audina

PY - 2019/2/1

Y1 - 2019/2/1

N2 - No consensus exists for the treatment of retinopathy in incontinentia pigmenti (IP). Vascular ischemia leads to tractional retinal detachments if untreated. Ultra-widefield fluorescein angiography (FA) is used to follow the vascular status of the retina. A 13-week-old female with IP presented with bilateral retinal vascular occlusions in both eyes. Ultra-widefield FA showed reperfusion after treatment with intravitreal bevacizumab (IVB) and angiography-guided laser to the avascular retina. Anti-vascular endothelial growth factor treatment reduces neovascularization and allows for growth of retinal vessels. IVB and FA-guided laser to the avascular retina is an option in IP.

AB - No consensus exists for the treatment of retinopathy in incontinentia pigmenti (IP). Vascular ischemia leads to tractional retinal detachments if untreated. Ultra-widefield fluorescein angiography (FA) is used to follow the vascular status of the retina. A 13-week-old female with IP presented with bilateral retinal vascular occlusions in both eyes. Ultra-widefield FA showed reperfusion after treatment with intravitreal bevacizumab (IVB) and angiography-guided laser to the avascular retina. Anti-vascular endothelial growth factor treatment reduces neovascularization and allows for growth of retinal vessels. IVB and FA-guided laser to the avascular retina is an option in IP.

UR - http://www.scopus.com/inward/record.url?scp=85061572610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061572610&partnerID=8YFLogxK

U2 - 10.3928/23258160-20190129-16

DO - 10.3928/23258160-20190129-16

M3 - Article

C2 - 30768227

AN - SCOPUS:85061572610

VL - 50

SP - E33-E37

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 2

ER -

Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this